 | Paul W. Hoelscher Sells 20,000 Shares of Horizon Therapeutics PLC (NASDAQ:HZNP) Stock
www.americanbankingnews.com - October 17 at 6:21 PM |
| Insider Selling: Horizon Therapeutics PLC (NASDAQ:HZNP) CEO Sells 320,174 Shares of Stock
www.americanbankingnews.com - October 17 at 6:21 PM |
 | Did Hedge Funds Drop The Ball On Horizon Therapeutics Public Limited Company (HZNP) ?
finance.yahoo.com - October 17 at 6:15 PM |
 | Horizon Therapeutics launches PROTECT trial evaluating KRYSTEXXA in uncontrolled gout
seekingalpha.com - October 17 at 1:13 PM |
| Is Horizon Therapeutics's (NASDAQ:HZNP) 128% Share Price Increase Well Justified?
finance.yahoo.com - October 17 at 1:13 PM |
| Is Horizon Therapeutics's (NASDAQ:HZNP) 128% Share Price Increase Well Justified?
finance.yahoo.com - October 17 at 1:13 PM |
| FORTUNE and Great Place to Work® Name Horizon Therapeutics plc to Best Small & Medium Workplaces List for Fourth Consecutive Year
finance.yahoo.com - October 17 at 1:13 PM |
| Horizon Therapeutics plc Initiates PROTECT Trial Evaluating KRYSTEXXA® (pegloticase injection) to Improve Management of Uncontrolled Gout for Adults with a Kidney Transplant
finance.yahoo.com - October 17 at 8:13 AM |
| Horizon Therapeutics PLC (NASDAQ:HZNP) Short Interest Update
www.americanbankingnews.com - October 15 at 6:11 AM |
| Horizon Therapeutics' Phase 3 trial finds 'significant benefit' of teprotumumab
seekingalpha.com - October 11 at 2:27 PM |
| New Data from Teprotumumab Phase 3 OPTIC Study Shows Significantly Reduced Double Vision and Improved Quality of Life for People with Active Thyroid Eye Disease
finance.yahoo.com - October 11 at 2:27 PM |
| For World Sight Day, Horizon and Prevent Blindness Are Calling on the Thyroid Eye Disease (TED) Community to Put “Vision First”
finance.yahoo.com - October 10 at 2:03 PM |
| $333.84 Million in Sales Expected for Horizon Therapeutics PLC (NASDAQ:HZNP) This Quarter
www.americanbankingnews.com - October 10 at 2:14 AM |
| Horizon Therapeutics plc to Release Third-Quarter 2019 Financial Results and Host Webcast on Nov. 6, 2019
finance.yahoo.com - October 9 at 12:45 PM |
| Zacks: Brokerages Anticipate Horizon Therapeutics PLC (NASDAQ:HZNP) to Post $0.51 EPS
www.americanbankingnews.com - October 8 at 9:19 PM |
| New Data Insights from the Phase 3 Teprotumumab Trial (OPTIC) to be Presented at the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Scientific Symposium
finance.yahoo.com - October 8 at 8:54 AM |
| Horizon Therapeutics plc Named One of the Best Adoption-Friendly Workplaces by the Dave Thomas Foundation for Adoption
finance.yahoo.com - October 3 at 4:59 PM |
| Horizon Therapeutics (NASDAQ:HZNP) Research Coverage Started at Bank of America
www.americanbankingnews.com - September 26 at 7:52 AM |
| Horizon Pharma plc (HZNP) Investor Presentation - Slideshow
seekingalpha.com - September 13 at 1:53 PM |
| Horizon's (HZNP) Eye Disease Drug Gets FDA's Priority Review
finance.yahoo.com - September 11 at 12:23 PM |
| Biotech Stock Roundup: AMGN's Lung Cancer Candidate, ALXN's Deal With Eidos in Focus
finance.yahoo.com - September 11 at 12:23 PM |
| Pharma Stocks Hammered As House Proposal Aims To Slash Drug Prices
finance.yahoo.com - September 10 at 12:53 PM |
| Horizon Therapeutics' Teprotumumab nabs accelerated review status for TED
seekingalpha.com - September 9 at 3:39 PM |
| Horizon Therapeutics: A Recession Resistant Pick With Upside Potential
seekingalpha.com - September 9 at 3:39 PM |
| Horizon Therapeutics plc Announces the FDA has Granted Priority Review of the Teprotumumab Biologics License Application (BLA) for the Treatment of Active Thyroid Eye Disease (TED)
finance.yahoo.com - September 9 at 3:39 PM |
| Why Is Horizon Therapeutics (HZNP) Down 3.3% Since Last Earnings Report?
finance.yahoo.com - September 6 at 1:34 PM |
| Is Horizon Therapeutics (NASDAQ:HZNP) Using Too Much Debt?
finance.yahoo.com - September 2 at 11:35 AM |
| Horizon Therapeutics plc Names Andy Pasternak Executive Vice President, Chief Business Officer
finance.yahoo.com - August 29 at 8:28 AM |
| American Journal of Ophthalmology (AJO) Publishes Review Highlighting Lack of Treatments for Active Thyroid Eye Disease (TED)
finance.yahoo.com - August 19 at 8:06 PM |
| Horizon Therapeutics plc to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
finance.yahoo.com - August 19 at 8:16 AM |
| Horizon Therapeutics Has 'Headroom For Value Creation,' BMO Says In Upgrade
finance.yahoo.com - August 14 at 8:08 PM |
| Horizon Therapeutics plc Collaborates with Rare Disease Advocates to Elevate Resources and Shared Experiences Through Launch of #RAREis™ Community Website
finance.yahoo.com - August 14 at 8:35 AM |
| Horizon Therapeutics Plc (HZNP) EVP, Corporate Affairs, CCO Geoffrey M. ...
finance.yahoo.com - August 12 at 11:20 PM |
| Horizon Therapeutics (HZNP) Surpasses Q2 Earnings and Revenue Estimates
finance.yahoo.com - August 7 at 11:13 PM |
| Horizon Pharma EPS beats by $0.12, beats on revenue
seekingalpha.com - August 7 at 9:18 AM |
| Horizon Pharma up 7% premarket on Q2 beat and raied guidance
seekingalpha.com - August 7 at 9:18 AM |
| Horizon Therapeutics plc Reports Strong Second-Quarter 2019 Results; Increases Full‐Year 2019 Net Sales and Adjusted EBITDA Guidance
finance.yahoo.com - August 7 at 9:18 AM |
| Horizon Earnings Unexpectedly Rise
finance.yahoo.com - August 7 at 9:18 AM |
| Horizon Pharma Q2 2019 Earnings Preview
seekingalpha.com - August 6 at 11:55 PM |
| Which Pharmaceutical Stocks Are Outperforming All Other Stocks?
finance.yahoo.com - August 6 at 9:04 AM |
 | HZNP Crosses Below Key Moving Average Level
www.nasdaq.com - August 5 at 11:42 PM |
| First Week of HZNP September 20th Options Trading
www.nasdaq.com - August 3 at 8:19 AM |
 | Horizon Therapeutics plc Appoints Dr. Sue Mahony to Board of Directors
www.marketwatch.com - August 1 at 9:00 AM |
| Earnings Preview: Horizon Therapeutics (HZNP) Q2 Earnings Expected to Decline
finance.yahoo.com - July 31 at 11:58 PM |
| Horizon Therapeutics plc Wins International CSR Excellence Award for Partnership with Perspectives Math and Science Academy
finance.yahoo.com - July 25 at 9:52 AM |
| Is Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) A Financially Sound Company?
finance.yahoo.com - July 19 at 9:04 AM |
| Horizon files U.S. application for packet formulation of Procysbi
seekingalpha.com - July 18 at 7:16 PM |
| Horizon Therapeutics plc Announces U.S. FDA Acceptance of its New Drug Application to Make PROCYSBI® (Cysteamine Bitartrate) Available as Oral Granules in Packets
finance.yahoo.com - July 18 at 7:16 PM |
| Horizon Therapeutics plc to Release Second-Quarter 2019 Financial Results and Host Webcast on Aug. 7, 2019
finance.yahoo.com - July 16 at 8:41 AM |
| Commit To Buy Horizon Therapeutics At $15, Earn 9% Using Options
www.nasdaq.com - July 15 at 7:02 PM |
